Peripheral

Top Story

DETOUR I: Percutaneous bypass procedure successful in long peripheral lesions

DETOUR I: Percutaneous bypass procedure successful in long peripheral lesions
September 22, 2017

A novel percutaneous bypass system using the femoral vein as a pathway conferred a high rate of patency with no effect on venous health in patients with very long superficial femoral artery lesions, according to data from VIVA 17.

Sean P. Lyden, MD, professor and chairman of the department of vascular surgery, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic and chief medical officer for Excelerate Strategic Health Sourcing, presented a subanalysis of 50 patients (mean age, 65 years; 84% men) with lesions longer than 25 cm from the DETOUR I trial of the PQ Detour procedure (PQ Bypass), a percutaneous technique in which revascularization is performed via modular stent graft bypass using the femoral vein as a conduit.

Meeting News

AcoArt I: Novel DCB successfully treats femoropopliteal disease at 2 years

September 20, 2017
A novel drug-coated balloon was associated with higher rates of patency and lower rates of target lesion revascularization at 2 years vs. percutaneous transluminal…
Meeting NewsPerspective

SAFE-DCB: High procedural success, few events in DCB registry

September 18, 2017
According to an interim analysis from a registry presented at VIVA 17, a drug-coated balloon was safe and effective at 12 months. Edward Y. Woo
Meeting NewsPerspective

Serration balloon catheter achieves low residual stenosis in PAD

September 15, 2017
LAS VEGAS — Results of the PRELUDE feasibility study of a serration balloon catheter showed it greatly reduced stenosis in patients with superficial femoral or…
More Headlines »
The Take Home

The Take Home: ESC

Cardiology Today's Intervention, September/October 2016
In late August, the European Society of Cardiology Congress brought together a record 33,000 cardiology professionals…
More »
Video
Meeting News Coverage

VIDEO: Diabetes may be risk equivalent for PAD, CAS

April 3, 2016
More »
Resource Centers
Meeting News

AcoArt I: Novel DCB successfully treats femoropopliteal disease at 2 years

September 20, 2017
A novel drug-coated balloon was associated with higher rates of patency and lower rates of target lesion…
More »
Advertisement
Advertisement